Vittia Annual Report 2022
VITTIA
Even in the face of the challenging 2022
landscape, which mixed a scenario of persistent
inflation, high interest rates, rising costs, the
War in Ukraine and unfavorable weather
events in several places in Brazil and in the
world, the year 2022 was one of achievements
and accomplishments for the Company. We
managed to stay on the path of growth in a
balanced, responsible, and sustainable way,
with adequate results.
Due to the quality and excellence of our
products, services and solutions, the
assertiveness of our management and
strategies, operational efficiency, continuous
improvement and permanent investment in
research, development, innovation, and high
technology, we closed the year with growth
rising, and increasingly gaining the trust and
preference of our customers and partners.
Main results
GRI 3-3
In the 2022 financial year, we presented a consistent growth, in general. We closed the year with:
▶ Net revenue of BRL 851.2 million (9.3% above 2021).
Adjusted EBITDA of BRL217.9 million (23.8% above 2021).
Net income of BRL 147.5 million (36.9% above 2021).
Also noteworthy:
In the Biological Products segment, net revenue was almost BRL 200 million (36.7% above 2021).
Investment of BRL 61.3 million in CAPEX (17.6% above 2021).
Investment of BRL 25.8 million in Research, Development, and Innovation (57.5% more than in 2021).
The main consolidated results are shown in the table below:
Economic-financial performance
In thousands of BRL
Net Revenue
Cost of product sold
Gross profit
Gross margin
Operational expenses
2022
851,191
(524,720)
326,471
38.4%
(145,203)
2021
Change %
778,915
(494,712)
9.3%
6.1%
284,203
14.9%
36.5%
1.9 p.p.
(141,364)
2.7%
Operating profit (loss)
181,268
142,839
26.9%
Adjusted EBITDA
217,896
176,069
23.8%
Adjusted EBITDA Margin
25.6%
22.6%
3.0 p.p.
Net financial result
(10,787)
(10,486)
2.9%
Income tax and social contribution
(22,996)
(24,614)
(6.6%)
Net income
147,485
107,740
36.9%
Net margin
17.3%
13.8%
3.5 p.p.
Investments (fixed and intangible)
61,315
52,132
17.6%
Annual Report 2022
114View entire presentation